SCHEMBL7410394

SCHEMBL7410394

COc1ccc(N2C(=O)c3c(c4ccccc4[nH]c3=O)C2=O)cc1

nearest known ligand 0.54

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
ADORA3 P0DMS8 4/20 0.54
ADORA1 P30542 2/20 0.54
NR1H3 Q13133 2/20 0.50
MEN1 O00255 3/20 0.48
KMT2A Q03164 3/20 0.48
ATM Q13315 1/20 0.48
ALDH1A1 P00352 3/20 0.46
SMN1; SMN2 Q16637 3/20 0.46
LMNA P02545 2/20 0.46
HPGD P15428 2/20 0.46
KDM4E B2RXH2 2/20 0.46
ABCG2 Q9UNQ0 1/20 0.46
ASAH1 Q13510 1/20 0.46
PADI4 Q9UM07 1/20 0.46
MAPT P10636 2/20 0.46
PTGS2 P35354 1/20 0.44
PTGER4 P35408 1/20 0.44
PTGS1 P23219 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7413449 0.87 ADORA3 (0.56) ADORA3ADORA1NR1H3MEN1KMT2A
SCHEMBL7415475 0.84 MAPT (0.49) ADORA3MEN1KMT2AATMALDH1A1
SCHEMBL7407990 0.82 MAPK14 (0.53) ADORA3MEN1KMT2AALDH1A1LMNA
SCHEMBL7412697 0.82 ADORA3 (0.51) ADORA3MEN1KMT2AATMALDH1A1
SCHEMBL7409290 0.79 MAPK14 (0.53) MEN1KMT2AALDH1A1SMN1; SMN2LMNA
SCHEMBL7413902 0.77 ADORA3 (0.50) ADORA3ADORA1MEN1KMT2AATM
SCHEMBL7409538 0.77 ADORA3 (0.50) ADORA3ADORA1MEN1KMT2AATM
SCHEMBL7415160 0.76 ADORA3 (0.54) ADORA3ADORA1MEN1KMT2AALDH1A1
SCHEMBL7415495 0.74 KDM4E (0.40) ADORA3ADORA1MEN1KMT2AALDH1A1
SCHEMBL7415108 0.73 CASP3 (0.55) ADORA3MEN1KMT2AALDH1A1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5243049-A Gamma-aminobutyric acid antagonist NEUROGEN CORPORATION (US) 1993-09-07 US claimed
US-5908932-A Certain pyrroloquinolinones; a new class of GABA brain receptor NEUROGEN CORPORATION (US) 1999-06-01 US disclosed
US-5604235-A DIAGNOSIS AND TREATMENT OF ANXIETY, SLEEP AND SEIZURE DISORDERS, BENZODIAZEPINE OVERDOSE; ENHANCEMENT OF MEMORY NEUROGEN CORPORATION (US) 1997-02-18 US disclosed
WO-1994026741-A1 CERTAIN PYRROLOQUINOLINONES; A NEW CLASS OF GABE BRAIN RECEPTOR LIGANDS NEUROGEN CORPORATION (US) 1994-11-24 WO disclosed
US-5243049-A Gamma-aminobutyric acid antagonist NEUROGEN CORPORATION (US) 1993-09-07 US disclosed